Intellia Therapeutics Inc
NASDAQ:NTLA

Watchlist Manager
Intellia Therapeutics Inc Logo
Intellia Therapeutics Inc
NASDAQ:NTLA
Watchlist
Price: 12.06 USD 3.79% Market Closed
Market Cap: 1.3B USD

Intrinsic Value

The intrinsic value of one NTLA stock under the Base Case scenario is hidden USD. Compared to the current market price of 12.06 USD, Intellia Therapeutics Inc is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

NTLA Intrinsic Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation History
Intellia Therapeutics Inc

Intrinsic Value History
Dive into the past to invest in the future

NTLA looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether NTLA usually does or if today's premium is unusual.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Compare NTLA to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about NTLA?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Intellia Therapeutics Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Intellia Therapeutics Inc

Current Assets 551.4m
Cash & Short-Term Investments 503.7m
Receivables 10.5m
Other Current Assets 37.1m
Non-Current Assets 434.8m
Long-Term Investments 228.1m
PP&E 163.1m
Other Non-Current Assets 43.6m
Efficiency

Free Cash Flow Analysis
Intellia Therapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Intellia Therapeutics Inc

Revenue
52.9m USD
Operating Expenses
-564.9m USD
Operating Income
-512m USD
Other Expenses
31.8m USD
Net Income
-480.2m USD
Fundamental Scores

NTLA Profitability Score
Profitability Due Diligence

Intellia Therapeutics Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

hidden
Profitability
Score

Intellia Therapeutics Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

NTLA Solvency Score
Solvency Due Diligence

Intellia Therapeutics Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Low D/E
Low Altman Z-Score
hidden
Solvency
Score

Intellia Therapeutics Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

NTLA Price Targets Summary
Intellia Therapeutics Inc

Wall Street analysts forecast NTLA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for NTLA is 33.84 USD with a low forecast of 7.07 USD and a high forecast of 111.3 USD.

Lowest
Price Target
7.07 USD
41% Downside
Average
Price Target
33.84 USD
181% Upside
Highest
Price Target
111.3 USD
823% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Intellia Therapeutics Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for NTLA is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

NTLA Insider Trading
Buy and sell transactions by insiders

NTLA News

Other Videos
What is the Intrinsic Value of one NTLA stock?

The intrinsic value of one NTLA stock under the Base Case scenario is hidden USD.

Is NTLA stock undervalued or overvalued?

Compared to the current market price of 12.06 USD, Intellia Therapeutics Inc is hidden .

Back to Top